Empower Clinics Inc (CSE:CBDT) (OTCQB:EPWCF) (FRA:8EC) said Thursday that its latest acquisition Kai Medical Laboratory is introducing its new KAI ABC RT-PCR test protocol that will differentiate between influenza A and B strains and COVID-19. In a statement, the Vancouver-based firm said the ability to differentiate between the viruses will be essential in the diagnosis and treatment of respiratory pathogens. Empower said the new test protocol should be ready to be rolled out in the first week of December, just in time for a recent 9,000-unit order for a film and television production that the company announced earlier in October. |